Histone Methylation and Oxidative Stress in Cardiovascular Diseases

Xin Yi1,2,3, Qiu-Xia Zhu1,2,3, Xing-Liang Wu1,2,3

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Insights

Oxidative stress and histone methylation are key in cardiovascular diseases. Understanding their interplay offers new therapeutic targets for conditions like atherosclerosis and hypertension.

Area of Science:

  • Cardiovascular Biology
  • Epigenetics
  • Oxidative Stress Research

Background:

  • Oxidative stress, caused by reactive oxygen species (ROS) overwhelming antioxidant defenses, is implicated in cardiovascular diseases.
  • Histone methylation is increasingly recognized as a regulator of oxidative stress.
  • The link between oxidative stress and histone methylation is critical for cardiovascular health and disease progression.

Purpose of the Study:

  • To review the interplay between histone methylation and oxidative stress in cardiovascular diseases.
  • To explore potential therapeutic strategies targeting this molecular mechanism.
  • To highlight the need for further research into bridging signaling pathways.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of studies on histone methylation and oxidative stress in cardiovascular contexts.
  • Examination of therapeutic implications of epigenetic modifications.

Main Results:

  • Histone methylation significantly influences oxidative stress levels in cardiovascular disease development.
  • Cardiovascular pathologies including atherosclerosis, coronary artery disease, pulmonary hypertension, and diabetic vascular complications are linked to this interplay.
  • Epigenetic modifiers show promise as therapeutic targets, similar to cancer treatments.

Conclusions:

  • Targeting the interplay between oxidative stress and histone methylation presents novel therapeutic avenues for cardiovascular disorders.
  • Further exploration of the comprehensive signaling pathways is essential for clinical translation.
  • This review consolidates current knowledge, guiding future research in cardiovascular epigenetics and oxidative stress.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
89
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
101
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
243
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
62